Symmetry Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-706
Closed -$23K 57
2017
Q1
$23K Buy
+706
New +$23K 0.01% 51